William Pao Archives
VU study identifies new gene fusions in melanoma
Dec. 19, 2013—Cancer researchers, led by investigators at Vanderbilt-Ingram Cancer Center, have identified two novel gene fusions in melanoma that may be responsive to existing cancer therapies. Melanoma is the most deadly form of skin cancer.
Probing mutant EGF receptor regulation
Oct. 10, 2013—Understanding the regulation of mutant EGF receptors commonly found in lung cancers could lead to new targeted therapies.
VU study identifies DNA changes in drug-resistant cancer cells
Sep. 12, 2013—Vanderbilt investigators have combined next-generation sequencing technologies and bioinformatics analyses to screen for genome-wide genetic mutations associated with drug resistance in a series of lung cancer cell lines.
Vanderbilt planning for the future
Jul. 5, 2013—An executive committee has been named and will meet regularly this summer to develop a framework of ideas to guide a university-wide academic strategic planning process that will set the course for Vanderbilt’s future.
Foundation lauds graduate student’s melanoma research
Mar. 28, 2013—Katherine Hutchinson, a third-year graduate student in Cancer Biology at Vanderbilt University, has won a $10,000 Research Scholar Award from the Joanna M. Nicolay Melanoma Foundation.
New endowed chair holders recognized
Dec. 20, 2012—Nine Vanderbilt University faculty members named to endowed chairs were honored for outstanding academic achievements last week during a celebration at the Student Life Center. “An endowed chair is the highest academic honor that a university can bestow on its faculty,” said University Provost and Vice Chancellor for Academic Affairs Richard McCarty, Ph.D. “It’s really...
Nine faculty honored at endowed chair celebration
Dec. 13, 2012—Nine Vanderbilt University faculty members named to endowed chairs were honored for outstanding academic achievements Dec. 12 during a celebration at the Student Life Center.
Photo: Lung Cancer Partnership
Sep. 27, 2012—Caroline Nebhan, right, a fourth-year student in the M.D./Ph.D. training program, explains a cancer research experiment to advocates from the National Lung Cancer Partnership who toured Vanderbilt-Ingram Cancer Center during their recent meeting in Nashville. Nebhan, who works in the research laboratory of William Pao, M.D., Ph.D., is studying the effects of a specific cancer...
HER2 may impact lung cancer therapy
Sep. 21, 2012—A protein associated with aggressive breast cancers may also influence resistance of lung cancer to targeted therapies.
Stand Up to Cancer TV broadcast airs Sept. 7
Aug. 30, 2012—Stand Up To Cancer (SU2C), the nonprofit organization that helps fund various Vanderbilt-Ingram Cancer Center (VICC) investigators, returns to prime time television for its third broadcast Friday, Sept. 7, at 7 p.m. The hourlong show featuring Hollywood celebrities, recording artists and sports figures will include special performances and a celebrity phone/multi-media bank that will allow...
Vanderbilt cancer investigators win two national GE cancer research grants
Mar. 28, 2012—Vanderbilt-Ingram Cancer Center investigators have won two of the five global innovation grants awarded by the “GE Healthymagination Cancer Challenge.”
Jeffrey Sosman named to melanoma research ‘Dream Team’
Dec. 15, 2011—Jeffrey Sosman, professor of medicine at Vanderbilt-Ingram Cancer Center (VICC), has been named to a melanoma research Dream Team of cancer investigators supported by Stand Up To Cancer (SU2C) and the Melanoma Research Alliance. Sosman is among the Dream Team’s principal investigators who will work closely to write the genomic-driven clinical trials and will lead...